| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/28/1992 | US5134075 Antitumor agents |
| 07/28/1992 | CA1305827C Spergualin-related compounds and process for producing the same |
| 07/28/1992 | CA1305699C 17-substituted androsta-1,4-dien-3-one derivatives |
| 07/28/1992 | CA1305678C Recombinant dna clone encoding laminin receptor |
| 07/28/1992 | CA1305665C Macromolecular platinum antitumor compounds |
| 07/26/1992 | WO1992012982A1 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof |
| 07/26/1992 | CA2057547A1 Vav proto-oncogene protein |
| 07/23/1992 | WO1992012154A1 Imidazotriazine derivatives |
| 07/23/1992 | WO1992012119A1 The effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/23/1992 | WO1992011867A1 Novel glucohydrolase inhibitors useful as antidiabetic agents |
| 07/23/1992 | WO1992005266A3 Packaging cells |
| 07/23/1992 | DE4101953A1 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel 23-oxa derivatives in the vitamin-d-series, methods for their manufacture pharmaceutical compositions containing these derivatives and their use as drug |
| 07/23/1992 | CA2098927A1 Novel glucohydrolase inhibitors useful as antidiabetic agents |
| 07/23/1992 | CA2097324A1 Effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/22/1992 | EP0495750A2 Heterocyclic hydroxylamine |
| 07/22/1992 | EP0495639A1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/22/1992 | EP0495528A1 New 3'-(4-morpholinyl)-anthracycline derivatives |
| 07/22/1992 | EP0495432A1 Hexa-cyclic compound |
| 07/22/1992 | EP0495265A1 Acid-labile linker molecules |
| 07/22/1992 | EP0495225A1 Process for the preparation of 3'fluoropyrimidine nucleosides |
| 07/22/1992 | EP0495014A1 Novel oxidized lipoproteins and methods for their preparation |
| 07/22/1992 | EP0494992A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 07/22/1992 | EP0175709B1 Substance, composition of matter and method of using same |
| 07/22/1992 | CN1062908A Substituted tricyclic compounds |
| 07/22/1992 | CN1062904A Antiproliferative substituted naphthalene compounds |
| 07/21/1992 | US5132416 Antitumor agents |
| 07/21/1992 | US5132413 Sugar chain |
| 07/21/1992 | US5132327 Anti-cancer compounds |
| 07/21/1992 | US5132323 Treatment of animals |
| 07/21/1992 | US5132315 Diphenyl substituted 1,2,3-triazole derivatives as anticarcinogenic agents |
| 07/21/1992 | US5132291 3'-Azido-3'deoxy-thymidine administering with a purine compound |
| 07/21/1992 | US5132290 Antitumor agents |
| 07/21/1992 | CA1305484C Bis-dioxopiperazine derivatives and process for preparation thereof |
| 07/21/1992 | CA1305480C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| 07/21/1992 | CA1305476C Bryostatins compositions and methods of use |
| 07/21/1992 | CA1305425C Anti-neoplastic spermine derivative |
| 07/19/1992 | WO1992013097A1 Hepatic growth factor receptor is the met proto-oncogene |
| 07/16/1992 | CA2059249A1 Process for the preparation of 3'-fluoropyrimidine nucleosides |
| 07/15/1992 | WO1992012174A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/15/1992 | EP0494819A1 Phenylimidazolidines, their process for fabrication, their application as medicaments and the pharmaceutical compositions containing them |
| 07/15/1992 | EP0494623A1 Acridine derivatives |
| 07/15/1992 | EP0413792B1 Products containing a lithium salt and a tumour necrosis factor |
| 07/15/1992 | CN1062735A T-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use |
| 07/15/1992 | CN1062731A Process for preparation of water soluble camptothecin analogs and intermediates thereof, compounds prepared by said process, and methods of use thereof |
| 07/15/1992 | CA2100549A1 Ligand growth factors that bind to the erbb-2 receptor protein and induce cellular responses |
| 07/15/1992 | CA2059184A1 Heterocyclic hydroxylamines |
| 07/14/1992 | US5130414 Isolation and structural elucidation of the cyclic peptide hymenistatin 1 |
| 07/14/1992 | US5130335 Tetralin esters of phenols or benzoic acids having retinoid like activity |
| 07/14/1992 | US5130308 Method of treating hormone dependent tumors with diamine-platinum (ii) complex compounds |
| 07/14/1992 | US5130302 Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/14/1992 | US5130145 Pharmaceutical compositions with anit-cancer activity and method for the treatment of cancer |
| 07/14/1992 | US5130130 Tumors as target cell for diagnosis |
| 07/14/1992 | US5130116 Radiotherapeutic immunoconjugates labeled with iodine-125 |
| 07/14/1992 | CA1305054C2 Encapsulation of antineoplastic agents in liposomes |
| 07/14/1992 | CA1305053C Synthetic polymeric drugs |
| 07/12/1992 | WO1992012132A1 Acridine derivatives |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011263A1 Method of making camptothecin and camptothecin analogs |
| 07/09/1992 | WO1992011033A1 Control of gene expression by ionizing radiation |
| 07/09/1992 | WO1992011031A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
| 07/08/1992 | EP0493883A1 Cyclic (hetero)acetals of nitro substituted benzaldehydes having anti-cancer activity |
| 07/08/1992 | EP0493686A1 Monoclonal antibodies to glycolipid carbohydrate chains |
| 07/08/1992 | EP0323462B1 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations |
| 07/08/1992 | CN1062529A Indole derivatives |
| 07/07/1992 | US5128493 Platinum complexes |
| 07/07/1992 | US5128479 Oxidized diphenylheteroalkanes |
| 07/07/1992 | US5128470 Aromatic carboxamides |
| 07/07/1992 | US5128345 Carcinostatic composition comprising indolquinolines |
| 07/07/1992 | US5128322 Agent for therapy |
| 07/07/1992 | US5128258 Iron-releasing monokines |
| 07/07/1992 | US5128152 Iron-containing compositions and method for treating cancer |
| 07/07/1992 | US5128126 Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions |
| 07/07/1992 | US5128119 Methods for technetium/rhenium labeling of f(ab1)2 fragments |
| 07/07/1992 | CA1304741C Heterocyclic compounds |
| 07/01/1992 | EP0493064A1 Deacetylcolchicine derivatives |
| 07/01/1992 | EP0492478A2 Tert-butyloxycarbonyl-L-tyrosyl-peptidoglycan monomer and 125 I-labelled derivative thereof, their preparation and use |
| 07/01/1992 | EP0491956A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
| 07/01/1992 | EP0491828A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 07/01/1992 | EP0491793A1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
| 07/01/1992 | EP0491755A1 Gamma glutamyl transferases for treating diseases |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 07/01/1992 | CA2058595A1 Acid-labile linker molecules |
| 06/30/1992 | US5126437 Aldophosphamide glycosides, a process for their preparation and their use as pharmaceutical active compounds |
| 06/30/1992 | US5126436 Antibiotics |
| 06/30/1992 | US5126371 Diarylacetylenes, their preparation and their use |
| 06/30/1992 | US5126149 Tellurium tetrahalide for treament of autoimmune deficiency syndrome |
| 06/30/1992 | US5126148 Produced by human hematopoietic cells |
| 06/30/1992 | CA1304383C 1-alkyl-1-sulfonyl-2-alkoxycarbonylsulfenyl hydrazines having antineoplastic activity |
| 06/30/1992 | CA1304359C Antitumor and antiviral compositions of marine origin |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/26/1992 | CA2058060A1 Deacetylcolchicine derivatives |
| 06/25/1992 | WO1992010573A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/25/1992 | WO1992010482A1 Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same |
| 06/25/1992 | WO1992010212A1 Anthracycline-conjugates |
| 06/25/1992 | WO1992010197A1 Substances of polypeptide nature useful in human therapy |